Becton, Dickinson and Company

(New York Stock Exchange)
Bullish +72

Becton, Dickinson and Company (NYSE:BDX) CEO Thomas Polen, Jr. Sells ...

πŸ“ˆ Becton, Dickinson and Company reported quarterly revenue of $5.27 billion, beating analyst estimates of $5.11 billion by $160 million.

πŸ’° The company posted earnings per share of $4.15, topping the consensus estimate of $4.07 by $0.08.

πŸ”„ BDX authorized a new share repurchase plan allowing the buyback of up to 10 million shares or 3.6% of outstanding equity.

πŸ’΅ The company declared a quarterly dividend of $1.06 per share, an increase from the previous quarter's $1.05 payout.

πŸ“‰ CEO Thomas Polen Jr. sold 2,993 shares for $628,530 under a pre-arranged Rule 10b5-1 trading plan, reducing his stake by 2.65%.

🏦 BlackRock Inc. increased its position in BDX by approximately $3.7 billion during the second quarter.

πŸ“ˆ State Street Corp boosted its holdings by 8.5%, adding over 1.1 million shares to its portfolio.

πŸ” Zacks Research upgraded BDX from a 'hold' rating to a 'strong-buy' rating in late October.

🎯 The consensus analyst target price for BDX is $195.47, with Jefferies Financial Group setting a high target of $242.

Bullish Signals
  • Revenue grew 5.4% year-over-year to $5.27 billion, exceeding analyst consensus estimates of $5.11 billion.
  • Earnings per share reached $4.15, beating the expected $4.07 by $0.08, demonstrating strong operational execution.
  • The company authorized a new share repurchase program for up to 10 million shares, signaling management confidence in the stock's valuation.
  • Becton, Dickinson and Company increased its quarterly dividend to $1.06 per share from the previous $1.05.
  • Major institutional investors including BlackRock, State Street, and First Eagle significantly increased their holdings in the second quarter.
  • Zacks Research upgraded the stock to a 'strong-buy' rating following the strong quarterly earnings beat.
Risk Factors
  • The CEO sold 2,993 shares worth $628,530, representing a 2.65% reduction in his personal stake, though executed under a pre-arranged trading plan.
  • Barclays initiated coverage with an 'underweight' rating and set a price objective of $165, which is below the current market price.
Full Analysis
Becton, Dickinson and Company (NYSE:BDX) reported strong quarterly financial results for the period ending in late October, with revenue reaching $5.27 billion, a 5.4% year-over-year increase that beat analyst consensus estimates of $5.11 billion. The company posted earnings per share of $4.15, surpassing the expected $4.07, while maintaining a net margin of 4.52% and a return on equity of 14.79%. This performance highlights the medical instruments supplier's ability to grow revenue and profitability in its core healthcare markets. Following the earnings release, the company announced a new share repurchase plan authorizing the buyback of up to 10 million shares, representing approximately 3.6% of its outstanding equity. Additionally, BDX declared a quarterly dividend of $1.06 per share, payable on December 31st to shareholders of record by December 10th. This marks an increase from the previous quarterly dividend of $1.05, reflecting a commitment to returning capital to investors despite a payout ratio exceeding 100%. Institutional investor sentiment remains robust, with major funds like BlackRock, State Street, and First Eagle increasing their stakes in the second quarter. Analyst consensus is moderately bullish, with an average target price of $195.47 and recent upgrades from Zacks Research to a 'strong-buy' rating. While CEO Thomas Polen Jr. sold shares under a pre-arranged plan, the broader market data suggests confidence in BDX's long-term trajectory.